foxo4 dri senolytic or senomorphic FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway Senolytics: charting a new course
Senolytics: charting a new course or enhancing existing anti tumor therapies? Cellular Oncology Springer Nature Link The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. FOXO4 DRI Peptide for Cellular Senescence and Anti Aging Research Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine
Pay in 4 interest-free payments of $5.80 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7


